Jardiance 25mg 10pcs

Uses of Jardiance 25 mg Tablet

• Type II Diabetes Mellitus
• Cardiovascular risk reduction and heart failure

Side Effects of Jardiance 25 mg Tablet

Common Side Effects:

• Low blood sugar levels (shaking, sweating, anxiety, fast heartbeat, excessive hunger, headache)
• Urinary tract infection (burning sensation, cloudy urine, pelvic or mid-back pain)
• Dehydration (thirst, light-headedness, fainting)
• Genital yeast infection (itching, burning, pain, rash, swelling)
• Frequent urination
• Itching, rash, or red skin
• Constipation

Uncommon/Rare Side Effects:

• Hives
• Bladder emptying discomfort
• Fournier’s gangrene (serious genital or perineum infection)

Emergency Situations: Cease Jardiance 25 mg Tablet and seek immediate medical attention for severe allergic reactions or diabetic ketoacidosis symptoms.

Managing Side Effects:

• Constipation: Increase fiber intake, hydrate, and exercise regularly.
• Hypoglycemia: Consume sugary items, monitor blood sugar, and consult a doctor if needed.
• Nausea/Vomiting: Take the medication with or after meals, avoid oily/spicy foods, and seek medical advice if symptoms persist.
• Stomach Pain: Rest, eat slowly, use a heating pad, and consult a doctor if the pain persists.

Quick Suggestions:

• Inform your doctor if you have type 1 diabetes, risk of dehydration, urinary tract infection with fever, or serious genital infections.
• Take the medicine at the same time every day for the ease of remembering.
• Do not change the dose or duration of use without consulting your doctor, as it may worsen your condition or lead to other complications.
• Monitor your blood sugar levels regularly.
• Do a regular follow-up visit so that your doctor can monitor your condition.
• Adapt some lifestyle changes such as eating a low-sugar and low-salt diet and indulging in physical activities.
• Always carry a sugar candy with you to counteract the unexpected lowering of blood sugar levels.

Indications:

It is used to:

• Manage type 2 diabetes mellitus
• Reduce the risk of heart disease in diabetic patients
• Manage heart failure (with symptoms due to a weak pump function of the heart)

Pharmacology

Empagliflozin is indeed an inhibitor of the sodium-glucose co-transporter-2 (SGLT-2). This class of medications, known as SGLT-2 inhibitors, primarily targets the SGLT2 co-transporters in the kidneys. These co-transporters play a crucial role in the reabsorption of glucose from the glomerular filtrate in the kidney.

By inhibiting SGLT-2, empagliflozin promotes glucuretic action. This means that it reduces the reabsorption of glucose by the kidneys, leading to increased glucose excretion in the urine. This process effectively lowers the renal glucose threshold, resulting in higher levels of glucose being expelled from the body through urine. By doing so, empagliflozin helps lower blood glucose levels, making it an effective medication for managing hyperglycemia in people with diabetes.

Additionally, the glucuretic action of empagliflozin can contribute to weight loss, as the body expels excess glucose calories through urine. Furthermore, the medication has been associated with lowering blood pressure, providing additional cardiovascular benefits for individuals with diabetes.

In summary, empagliflozin's mechanism of action involves inhibiting SGLT-2, leading to increased urinary excretion of glucose, weight loss, and beneficial effects on blood pressure, all contributing to the management of hyperglycemia in individuals with diabetes.

Dosage & Administration:

Follow your physician's advice when takingJardiance 25. Swallow the tablet with a glass of water without crushing or chewing. The appropriate dose and duration will be determined by your doctor based on factors such as age, body weight, and medical condition. Do not discontinue the medication unless advised by your doctor.

Interaction

Discuss with your doctor if taking diuretics or sulphonylureas.

Contraindications

Patients having a history of serious allergic reactions to Empagliflozin or any of its constituents, severe renal impairment, end-stage renal disease, or dialysis should not take Empagliflozin.

Pregnancy & Lactation

Assessment of renal function is recommended before initiation of Empagliflozin and periodically thereafter. Empagliflozin should not initiated in patients with an eGFR less than 45 ml/min/1.73 m2. No dose adjustment is needed in patients with an eGFR greater than or equal to 45 ml/min/1.73 m2.

Precautions & Warnings

• Contraindicated in pregnancy and breastfeeding.
• Caution while driving if feeling dizzy.
• Use with caution in severe kidney or liver disease.
• Avoid if allergic to Empagliflozin.
• Not recommended for children; the elderly consult their doctor.

Storage Conditions

Keep away from light and moisture in a cool, dry location (below 30° C). Keep out of children's reach.